Evidence map›Paper›PMID 28314949›Full record

ArticlePsychopharmacology2017

Tolerance and cross-tolerance to the antinociceptive effects of oxycodone and the imidazoline I

David A Thorn, Yanan Zhang, Jun-Xu Li

Abstract read
In one paragraph

Article in Psychopharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. The Use of the Selective Imidazoline INeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2020
    Article
  5. Article
  6. The imidazoline IBiochemical pharmacology · 2018
    Article
  7. Neuroanatomical characterization of imidazoline IThe European journal of neuroscience · 2018
    Article
  8. Mechanisms of imidazoline IBritish journal of pharmacology · 2018
    Article
  9. Imidazoline IPharmacology & therapeutics · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

David A ThornDepartment of Pharmacology and Toxicology, University at Buffalo, Buffalo, NY, USA.
Yanan ZhangResearch Triangle Institute, Research Triangle Park, NC, USA.
Jun-Xu LiDepartment of Pharmacology and Toxicology, University at Buffalo, Buffalo, NY, USA. junxuli@buffalo.edu.
RTI International · USUniversity at Buffalo, State University of New York · US

Funding

IMIDAZOLINE I2 RECEPTORS AS TARGETS FOR THE TREATMENT OF PAINR01DA034806 · NIDA · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI LI, JUN-XU · 2013 to 2017
$1.7M
NIDA NIH HHS R01 DA034806
6 · The paper itself

Abstract

rationaleEmerging evidence suggests the potential utility of combining opioids with imidazoline I

objectiveThis study examined the anti-hyperalgesic effect of the opioid oxycodone, the selective I

methodsVon Frey filament test was used to examine the anti-hyperalgesic effect of drugs in complete Freund's adjuvant (CFA)-induced inflammatory pain or chronic constriction injury (CCI)-induced neuropathic pain in rats. Twice-daily treatment with oxycodone and phenyzoline, alone or in combination, was continued until the development of significant tolerance (oxycodone) or as long as 19 days passed (phenyzoline).

resultsIn rats receiving CFA or CCI manipulation, mechanical hyperalgesia was dose-dependently reversed by oxycodone and phenyzoline. Twice-daily treatment with 2 × ED

conclusionsCombination therapy with oxycodone and I

Indexed as

Drug ToleranceAnalgesicsAnalgesics, OpioidAnimalsDose-Response Relationship, DrugDrug Therapy, CombinationImidazoline ReceptorsImidazolinesMaleOxycodonePainPain MeasurementRatsRats, Sprague-DawleyAnalgesicsAnalgesics, Opioidimidazoline receptor 2Imidazoline ReceptorsImidazolinesOxycodonephenyzolineImidazoline I2 receptorOxycodonePainPhenyzolineRatsTolerance

Identifiers

PMID28314949
PMCPMC5451304
OpenAlexW2595855852

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.